Researchers in two new studies say they can leverage the body’s own antibodies to fight the virus that causes AIDS. In the field of HIV research, antibodies continue to be a targeted area. Two new studies published January 19 in Science Translational Medicine offer potential new treatment ...

For the first time in the United States, a 31-year-old male with primary sclerosing cholangitis received a liver transplant from a deceased donor infected with hepatitis C virus (HCV). Primary sclerosis cholangitis slowly damages the bile ducts in the liver. After Lorenzo Swank learned his liver ...

Agonist therapy with methadone could use existing structure to reduce addiction, HIV Opioid agonist therapy using methadone is regarded as one of the most effective treatments for opioid use disorders as well as helping to reduce HIV risks. Such therapy, however, is not yet available in ...

GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today (January 23) the initiation of the next human clinical trial of GeoVax’s preventive HIV vaccine, GOVX-B11. The Phase 1 trial (designated HVTN 114) is being conducted by the HIV Vaccine Trials Network ...

European Medicines Agency validates Gilead’s Marketing Authorization Application for investigational chronic hepatitis C therapy sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) SOF/VEL/VOX granted an accelerated assessment by the European Medicines Agency FOSTER CITY, Calif., Jan. 20, 2017– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Marketing Authorization Application (MAA) for ...

For the past two years, Rachel King, PhD, MPH, an academic coordinator at UCSF Global Health Sciences, has been helping Ugandan parents and caregivers find developmentally appropriate ways to tell their children that the child has HIV. There are an estimated 150,000 HIV-infected children in Uganda, ...

Kaiser Family Foundation: The Global HIV/AIDS Epidemic This updated fact sheet provides information on current HIV prevalence and incidence, prevention and treatment strategies, and the U.S. and global responses to the epidemic (1/19). Kaiser Family Foundation: The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) This updated fact ...

Long-term care for an aging HIV population is uncharted territory, as researchers and physicians are seeing the effects of the first wave of individuals who have been on antiretroviral therapy (ART) for a significant period of time. An increasing amount of academic and clinical research has ...

Providing pre-exposure prophylaxis (PrEP) to people who need it entails at least nine key steps, which can be conceived of as a PrEP continuum of care, according to an article published online ahead of print by Amy Nunn and colleagues in AIDS. This continuum can ...

Targeting chronic hepatitis B infections affecting more than 240 million people worldwide GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today (January 17) that it has entered into a research collaboration agreement with Georgia State University Research Foundation (GSU) to advance the ...

Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, ...

DPP® HIV-Syphilis Assay on track for U.S. regulatory submission in 2017 MEDFORD, N.Y., Jan. 17, 2017 — Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received a CE mark for its DPP® HIV-Syphilis combination assay. ...

GENEVA, 17 January – UNITAID is calling for proposals to create and accelerate the demand for and adoption of HIV self-testing (HIVST) in low and middle-income countries, particularly among underserved populations at high risk of HIV infection. While access to HIV testing services has increased significantly ...

A questionnaire from the president-elect’s transition team asked whether the extraordinarily successful PEPFAR had become a “massive, international entitlement program,” and whether it was worth the investment. In 2003, in a move that has been described as his greatest legacy, George W. Bush created a program ...

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men’s susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections. This might explain why new and repeat cases in these groups have risen so sharply ...

Great advances in science often come from outside the direct field of research. Since the early days of the epidemic, the HIV research community brought together clinicians, virologists, social scientists, and community members to try to shed light on the devastating disease. More than 30 years ...

The vast majority of people taking antiretroviral therapy (ART) in the UK have an accurate knowledge of their current viral load (VL) level, investigators report in HIV Medicine. Overall, 96% of people who told researchers their viral load was undetectable had a clinic-recorded viral load ...

On January 16 the Scottish Medicines Consortium (SMC) published advice accepting Zepatier for routine use in NHS Scotland. Elbasvir-grazoprevir (Zepatier) was accepted for the treatment of chronic hepatitis C. Elbasvir-grazoprevir is a combination of two medicines that inhibit the replication of the hepatitis C virus and ...